Medipost Employees Visit Heungkye Hospital
Sharing Real-World Clinical Experience and Surgical Expertise

Heungkye Hospital CEO Kim Jonggeun Shares Cartistem Clinical Experience Through On-site Lecture and Surgery Demonstration View original image

Heungkye Hospital, located in Siheung, announced that on April 1, 2026, CEO and Medical Director Kim Jonggeun personally delivered a lecture and performed a live surgery demonstration for employees of Medipost's Cartistem business division, sharing his experience with Cartistem treatments and real-world clinical application cases. This program was organized to enhance understanding of the treatment process and promote practical, field-based exchange, drawing on the clinical experience and surgical expertise accumulated at Heungkye Hospital.


Approximately 20 employees from the Medipost Cartistem business division attended the event. The program began with an introduction to the hospital, followed by observation of an actual surgery, and concluded with a lecture by CEO and Medical Director Kim Jonggeun. In his lecture, Kim Jonggeun explained practical points for utilizing Cartistem in real clinical settings, focusing on treatment experience and clinical application cases. During the live surgery demonstration, he provided a direct overview of the entire treatment process and highlighted the key elements of on-site decision-making.


The attendees showed great interest as they witnessed firsthand how clinical experience accumulated in actual medical settings is reflected in treatment. CEO and Medical Director Kim Jonggeun explained that Cartistem is the only stem cell therapy for cartilage regeneration that has been approved as a prescription medicine, and that, based on approximately 7.5 million cells, it offers consistent treatment outcomes. He also emphasized that, as it is derived from umbilical cord blood cells, it can be applied without age restrictions. In addition, he shared that positive clinical experience has been accumulated even among elderly patient groups, helping participants gain a deeper understanding.

Heungkye Hospital CEO Kim Jonggeun Shares Cartistem Clinical Experience Through On-site Lecture and Surgery Demonstration View original image

Heungkye Hospital stated that this program was meaningful not only as a simple visit but also as an opportunity to share the hospital's accumulated clinical experience and expertise directly with external stakeholders. In particular, CEO and Medical Director Kim Jonggeun demonstrated the hospital's field-oriented medical capabilities by delivering both a lecture and a surgery demonstration, following his presentation of a minimally invasive knee arthroplasty surgery at KIMES 2026 earlier this year. In addition, with the educational experience gained through last year's cadaver training, it became clear that clinical care, education, and research are naturally interconnected as part of a continuous flow at the hospital.


Kim Jonggeun, CEO and Medical Director of Heungkye Hospital, stated, "This program was meaningful in that I was able to directly share case studies and treatment strategies for Cartistem based on experience accumulated in real clinical settings. Going forward, Heungkye Hospital will continue to expand opportunities for research, education, and exchange, based on clinical experience gained in the field, to further enhance the quality of patient care."



He continued, "Starting with this program, a follow-up event is also scheduled at the Cartistem headquarters in the second half of this year. Heungkye Hospital plans to continue creating opportunities for clinical care, education, and academic exchange to be closely integrated in the future."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing